Stockrabit · Analysts
Questions across 1 call

Omkar Kamatekar

Bonanza Portfolio

Natco Pharma Limited

Natco Pharma Limited CC-Dec23.pdf · 2024-02-15
Yes, so my first question is with respect to capex. Approximately, what is the amount of capex that we have incurred in the current year? And what will be the steady-state capex which we are going to incur in the next couple of years? Because you've added approximately 50% capex in the last 4 years, from INR2,100 crores in FY '19 to now, as of FY '23, 57% capex has been -- of gross block has increased. Is most of the capex done? Or we still -- there will be another round of capex?
Got it,. So, my question was with respect to so the point was because of this increased capex our fixed asset turnover, gross block to t urnover had gone down and we'll be close to 1 by the end of this year, FY '24, close to INR4,000 crores of turnover. So we'll be slightly above 1. Historically, before the round of capex, we were above 1.3, 1.4. So would those be the levels that we'll be r eaching? So, what will be the maturity time for these capacities to reach optimal level, so we might see 1.4, 1.5x the gross block turnovers?